Arcoma AB (ARCOMA.ST)

Sweden · Healthcare · SEK

Key financials

ROE: 7.5%; 2025 (actual)
ROA: 5.68%; 2025 (actual)
Gross Margin: 40.73%; 2025 (actual)
Net Margin: 3.85%; 2025 (actual)
Total Assets: SEK 96,651.00K; 2025 (actual)
Net Income: SEK 5,030.00K; 2025 (actual)
Valuation: SEK 105,024.46K; 2025 (actual)
Stock Price: SEK 7.34; 2025 (actual)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026	2027	2028	2029	2030
ROE	7.5%	6.79%	7.01%	7.44%	7.7%	7.6%
ROA	5.68%	5.28%	5.45%	5.72%	5.86%	5.76%
Gross Margin	40.73%	40.73%	40.73%	40.73%	40.73%	40.73%
Sector average	16.85%	17.71%	17.71%	17.71%	17.71%	17.71%
Net Margin	3.85%	3.91%	3.9%	3.89%	3.88%	3.88%

Amounts in SEK (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2025. Projections are model estimates, not investment advice.

Want the full financial forecast report for Arcoma AB? It covers the balance sheet, income statement and Equlion model projections.

Total Assets	SEK 96,651.00K	SEK 102,479.14K	SEK 110,732.01K	SEK 120,970.06K	SEK 131,798.62K	SEK 141,806.58K
Sector average	SEK 2,857,190.78K	SEK 2,900,240.60K	SEK 3,045,009.79K	SEK 3,280,286.42K	SEK 3,536,407.14K	SEK 3,762,908.71K

Net Income	SEK 5,030.00K	SEK 5,254.73K	SEK 5,806.43K	SEK 6,625.87K	SEK 7,403.00K	SEK 7,884.73K
Sector average	-SEK 2,851.32K	-SEK 22,027.28K	-SEK 904.69K	-SEK 7,253.84K	-SEK 3,858.45K	-SEK 1,547.00K

Valuation	SEK 105,024.46K	SEK 107,228.81K	SEK 109,422.33K	SEK 111,541.16K	SEK 113,601.13K	SEK 115,683.17K
Sector average	SEK 3,960,502.41K	SEK 5,151,301.60K	SEK 5,189,236.02K	SEK 5,317,343.69K	SEK 5,514,329.75K	SEK 5,636,782.17K

Stock Price	SEK 7.34	SEK 7.49	SEK 7.65	SEK 7.80	SEK 7.94	SEK 8.08
Sector average	SEK 57.22	SEK 48.04	SEK 48.69	SEK 50.45	SEK 52.13	SEK 53.41